343.60001 EUR
2
0.58%
Last update Nov 18, 4:21 PM CET
Main market
Day range
343.60001
343.60001
Previous close
345.60001
Open
343.60001
Access this stock data via API
Subscribe
Alnylam Pharmaceuticals Inc.
343.60
2
0.58%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 1.1B 659.4M 506.4M 505.5M
Cost of revenue 170.6M 121.8M 60.5M 87.6M
Gross profit 893.9M 537.5M 445.9M 417.9M
Operating expense
Research & development 305.8M 275.8M 226.0M 255.8M
Selling general and admin 274.5M 275.5M 204.5M 251.7M
Other operating expenses
Operating income 313.6M -13.8M 15.4M -89.6M
Non operating interest income
Income 24.4M 23.4M 24.4M 26.4M
Expense 37.8M 34.3M 32.9M 33.2M
Other income expense -96.6M -5.5M -42.4M -68.9M
Pretax income 203.7M -30.1M -35.5M -165.3M
Tax provision -10.3M 26.4M 13.5M -93.9M
Net income 214.0M -56.5M -49.0M -71.4M
Basic EPS -0.5 -0.4
Diluted EPS -0.5 -0.4
Basic average shares 111.3M 110.5M
Diluted average shares 111.3M 110.5M
EBITDA 341.7M 30.2M 60.8M -72.1M
Net income from continuing op. 214.0M -56.5M -49.0M -71.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 5 hours 16 minutes

12:13
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).